Cannabinoid transmission and reward-related events

被引:183
作者
Gardner, EL [1 ]
Vorel, SR
机构
[1] Albert Einstein Coll Med, Dept Psychiat, Bronx, NY 10461 USA
[2] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA
关键词
cannabis; cannabinoid; marijuana; reward; reinforcement; brain stimulation; ICSS; microdialysis; place preference; dopamine; nucleus accumbens; medial forebrain bundle; ventral tegmental area; addiction; dependence; drug abuse;
D O I
10.1006/nbdi.1998.0219
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The reward/reinforcement circuitry of the mammalian brain consists of synaptically interconnected neurons associated with the medial forebrain bundle, linking the ventral tegmental area, nucleus accumbens, and ventral pallidum. Electrical stimulation of this circuit supports intense self-stimulation in animals and, in humans, produces intense pleasure or euphoria. This circuit is strongly implicated in the neural substrates of drug addiction and in such addiction-related phenomena as withdrawal dysphoria and craving. This circuit is also implicated in the pleasures produced by natural rewards (e.g., food, sex). Cannabinoids are euphorigenic in humans and have addictive liability in vulnerable persons, but were long considered "anomalous" drugs of abuse, lacking pharmacological interaction with these brain reward substrates. It is now clear, however, that cannabinoids activate these brain substrates and influence reward-related behaviors. From these actions, presumably, derive both the abuse potential of cannabinoids and the possible clinical efficacy in dysphoric states. (C) 1998 Academic Press.
引用
收藏
页码:502 / 533
页数:32
相关论文
共 312 条
  • [1] DEPRESSION OF MESOLIMBIC DOPAMINE TRANSMISSION AND SENSITIZATION TO MORPHINE DURING OPIATE ABSTINENCE
    ACQUAS, E
    DICHIARA, G
    [J]. JOURNAL OF NEUROCHEMISTRY, 1992, 58 (05) : 1620 - 1625
  • [2] ALI SF, 1989, NEUROTOXICOLOGY, V10, P491
  • [3] [Anonymous], CANNABIS ITS DERIVAT
  • [4] Comparative Epidemiology of Dependence on Tobacco, Alcohol, Controlled Substances, and Inhalants: Basic Findings From the National Comorbidity Survey
    Anthony, James C.
    Warner, Lynn A.
    Kessler, Ronald C.
    [J]. EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, 1994, 2 (03) : 244 - 268
  • [5] Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors
    Arnone, M
    Maruani, J
    Chaperon, F
    Thiebot, MH
    Poncelet, M
    Soubrie, P
    LeFur, G
    [J]. PSYCHOPHARMACOLOGY, 1997, 132 (01) : 104 - 106
  • [6] BANERJEE SP, 1975, J PHARMACOL EXP THER, V194, P74
  • [7] Cannabinomimetic behavioral effects of and adenylate cyclase inhibition by two new endogenous anandamides
    Barg, J
    Fride, E
    Hanus, L
    Levy, R
    MatusLeibovitch, N
    Heldman, E
    Bayewitch, M
    Mechoulam, R
    Vogel, Z
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 287 (02) : 145 - 152
  • [8] REWARD SYSTEM DEPRESSION FOLLOWING CHRONIC AMPHETAMINE - ANTAGONISM BY HALOPERIDOL
    BARRETT, RJ
    WHITE, DK
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1980, 13 (04) : 555 - 559
  • [9] BARTH F, 1995, M INT CANN RES SOC S
  • [10] INHIBITION OF NALOXONE-INDUCED WITHDRAWAL IN MORPHINE-DEPENDENT MICE BY "L-TRANS-DELTA9-TETRAHYDROCANNABINOL
    BHARGAVA, HN
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1976, 36 (01) : 259 - 262